Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women

Journal of Endocrinology

Volumn 206, Issue 2, 2010, Pages 217-224

  Corcoran, Michael P ^a   Meydani, Mohsen ^a   Lichtenstein, Alice H ^a   Schaefer, Ernst J ^a   Dillard, Alice ^a   Lamon Fava, Stefania ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ESTROGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; SEX HORMONE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; ESTRADIOL;

ADULT; AGED; AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; ISCHEMIC HEART DISEASE; MACROPHAGE; MALE; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; BLOOD; CORONARY ARTERY DISEASE; METABOLISM; MIDDLE AGED; MONOCYTE; REFERENCE VALUE;

AGED; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY DISEASE; CYTOKINES; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; POSTMENOPAUSE; REFERENCE VALUES; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955082188     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0057     Document Type: Article

References (47)

1. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH & Schaefer EJ 2008 Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. American Journal of Cardiology 101 315-318. (Pubitemid 351175627)
2. Bisoendial RJ, Kastelein JJ, Peters SL, Levels JH, Birjmohun R, Rotmans JI, Hartman D, Meijers JC, Levi M & Stroes ES 2007 Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. Journal of Lipid Research 48 952-960.
3. Brown MS & Goldstein JL 1983 Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annual Reviews of Biochemistry 52 223-261.
4. Calabro P, Willerson JT & Yeh ET 2003 Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 1930-1932.
5. Calippe B, Douin-Echinard V, Laffargue M, Laurell H, Rana-Poussine V, Pipy B, Guery JC, Bayard F, Arnal JF & Gourdy P 2008 Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. Journal of Immunology 180 7980-7988.
6. Cathcart MK, McNally AK & Chisolm GM 1991 Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. Journal of Lipid Research 32 63-70.
7. Chao TC, Van Alten PJ, Greager JA & Walter RJ1995 1995 Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cellular Immunology 160 43-49.
8. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, KesslerC, Judd HL, Sakkinen PA & Tracy RP 1999 Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 100 717-722. (Pubitemid 29383641)
9. Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Coviello DA, Carabbio C, Felli L, Miceli D, Farruggio R et al. 1996 Androgen and estrogen receptors are present in primarycultures of human synovial macrophages. Journal of Clinical Endocrinology and Metabolism 81 820-827.
10. Cutolo M, Capellino S, Montagna P, Ghiorzo P, Sulli A & Villaggio B 2005 Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Research and Therapy 7 R1124-R1132.
11. D'Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, Farruggio R, Miceli DM, Miele M, Castagnetta L et al. 1999 Sex hormones modulate inflammatory mediators produced by macrophages. Annals of the New York Academy of Sciences 876 426-429. (Pubitemid 29352154)
12. Death AK, McGrath KC, Sader MA, Nakhla S, Jessup W, Handelsman DJ & Celermajer DS 2004 Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology 145 1889-1897. (Pubitemid 38402398)
13. Gao H, Bryzgalova G, Hedman E, Khan A, Efendic S, Gustafsson JA & Dahlman-Wright K 2006 Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Molecular Endocrinology 20 1287-1299. (Pubitemid 43801232)
14. Ghisletti S, Meda C, Maggi A & Vegeto E 2005 17β-Estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Molecular and Cellular Biology 25 2957-2968. (Pubitemid 40464301)
15. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A & Pols HA 2002 Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. Journal of Clinical Endocrinology and Metabolism 87 3632-3639. (Pubitemid 34879505)
16. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T & Uchida K 2002 Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Letters 530 129-132. (Pubitemid 35248198)
17. Herrington DM, Howard TD,Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA & Bleecker ER 2002 Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New England Journal of Medicine 346 967-974.
18. Hodis HN, St John JA, Xiang M, Cushman M, Lobo RA & Mack WJ 2008 Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial). American Journal of Cardiology 101 1131-1133.
19. Itoh Y, Hayashi H, Xu J, Takii T, Miyazawa K, Ariga H, Akahoshi T, Waguri-Nagaya Y, Otsuka T, Okamoto T et al. 2007 Dihydrotestosterone inhibits tumor necrosis factor α induced interleukin-1α mRNA expression in rheumatoid fibroblast-like synovial cells. Biological and Pharmaceutical Bulletin 30 1140-1143.
20. Kanda N, Tsuchida T & Tamaki K 1996 Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clinical and Experimental Immunology 106 410-415. (Pubitemid 26359912)
21. Kanda N, Tsuchida T & Tamaki K 1997 Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis and Rheumatism 40 1703-1711. (Pubitemid 27426165)
22. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H et al. 2003 Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arteriosclerosis, Thrombosis, and Vascular Biology 23 1398-1404.
23. Kramer PR, Kramer SF & Guan G 2004 17β-Estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis and Rheumatism 50 1967-1975. (Pubitemid 38725109)
24. Krauss RM & Siri PW 2004 Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinology and Metabolism Clinics of North America 33 405-415.
25. Lakoski SG & Herrington DM 2005 Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article. Climacteric 8 317-326. (Pubitemid 41617480)
26. Li Q & Verma IM 2002 NF-κB regulation in the immune system. Nature Reviews. Immunology 2 725-734.
27. Li L, Roumeliotis N, Sawamura T & Renier G 2004 C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circulation Research 95 877-883. (Pubitemid 39435002)
28. Libby P 2002 Inflammation in atherosclerosis. Nature 420 868-874.
29. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE &Rothblat G 1994 A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arteriosclerosis and Thrombosis 14 1056-1065.
30. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K et al. 2009 Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 480-486.
31. Millar JS & Packard CJ 1998 Heterogeneity of apolipoprotein B-100-containing lipoprotein: what we have learnt from kinetic studies. Current Opinion in Lipidology 9 197-202.
32. Mor G, Eliza M, Song J, Wiita B, Chen S & Naftolin F 2001 17α-Methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture. Journal of Steroid Biochemistry and Molecular Biology 79 239-246.
33. Muzzio ML, Berg G, Zago V, Basilio F, Sanguinetti S, Lopez G, Brites F, Wikinski R & Schreier L 2007 Circulating small dense LDL, endothelial injuring factors and fibronectin in healthy postmenopausal women. Clinica Chimica Acta 381 157-163.
34. Norata GD, Raselli S, Grigore L, Garlaschelli K, Vianello D, Bertocco S, Zambon A & Catapano AL 2009 Small dense LDL and VLDL predict common carotid artery IMTand elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 206 556-562.
35. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB & Ridker PM 2002 Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. Journal of the American Medical Association 288 980-987.
36. Rossouw JE, Prentice RL, Manson JE,Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL & Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Journal of the American Medical Association 297 1465-1477.
37. Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S & Jialal I 2008 Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. Journal of Lipid Research 49 1015-1023.
38. Soucy G, Boivin G, Labrie F & Rivest S 2005 Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. Journal of Immunology 174 6391-6398. (Pubitemid 40663832)
39. Tipping PG & Hancock WW 1993 Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. American Journal of Pathology 142 1721-1728. (Pubitemid 24057066)
40. Torres JL & Ridker PM 2003 Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Current Opinion in Cardiology 18 471-478.
41. Vakkilainen J, Steiner G, Ansquer JC, Aubin F, Rattier S, Foucher C, Hamsten A & Taskinen MR 2003 Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107 1733-1737. (Pubitemid 36418352)
42. Valente AJ, Rozek MM, Sprague EA & Schwartz CJ 1992 Mechanisms in intimal monocyte - macrophage recruitment. A special role for monocyte chemotactic protein-1. Circulation 86 III20-III25.
43. Vieira OV, Laranjinha JA, Madeira VM & Almeida LM 1996 Rapid isolation of low density lipoproteins in a concentrated fraction free from water-soluble plasma antioxidants. Journal of Lipid Research 37 2715-2721.
44. Williams TN, Zhang CX, Game BA, He L & Huang Y 2004 C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arteriosclerosis, Thrombosis, and Vascular Biology 24 61-66.
45. Yasojima K, Schwab C, McGeer EG & McGeer PL 2001 Generation of C-reactive protein and complement components in atherosclerotic plaques. American Journal of Pathology 158 1039-1051. (Pubitemid 32221796)
46. Yesilova Z, Ozata M, Kocar IH, Turan M, Pekel A, Sengul A & Ozdemir IC 2000 The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 85 66-70. (Pubitemid 32268791)
47. Zegura B, Keber I, Sebestjen M& KoenigW2003 Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. Atherosclerosis 168 123-129.